Professor Michael Clague - 'Ubiquitin: receptor sorting and selective autophagy'
1:00pm - 2:00pm /
Thursday 9th October 2025
/ Venue: Physiology seminar room Nuffield Wing
Type: Seminar /
Category: Research
/ Series: Institute of Systems, Molecular and Integrative Biology
- ISMIB Seminar Team
- Admission: Free, no registration required.
Add this event to my calendar
Click on "Create a calendar file" and your browser will download a .ics file for this event.
Microsoft Outlook: Download the file, double-click it to open it in Outlook, then click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open & Export, then Open Calendar. Select your .ics file then click on "Save & Close".
Google Calendar: download the file, then go into your calendar. On the left where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.
Apple Calendar: The file may open automatically with an option to save it to your calendar. If not, download the file, then you can either drag it to Calendar or import the file by going to File >Import > Import and choosing the .ics file.
Michael Clague obtained a PhD in biological chemistry from University of Essex. For postdoctoral work he moved to NIH, Bethesda, USA to study the biophysics of membrane fusion. An EMBO long term fellowship allowed him to move to EMBL, Heidelberg, to study cell biology (membrane trafficking) for the first time. He was then appointed to a faculty position at Liverpool , where he is currently Professor of Molecular and Cellular Physiology.
Early work at Liverpool focused on the role of phosphoinositide metabolism along the endocytic pathway. He was drawn into the ubiquitin field through studies of the MET receptor trafficking itinerary and has since developed a specific interest in the family of deubiquitylases. Working together with Sylvie Urbé, he investigates these enzymes in pathways germane to cancer and neurodegeneration. Contributions span foundational biology to development and characterisation of tool compound inhibitors. Work on USP30 has helped establish it as an actionable target for Parkinson’s Disease and led to a broader interest in mitophagy and pexophagy pathways.
All welcome.
Early work at Liverpool focused on the role of phosphoinositide metabolism along the endocytic pathway. He was drawn into the ubiquitin field through studies of the MET receptor trafficking itinerary and has since developed a specific interest in the family of deubiquitylases. Working together with Sylvie Urbé, he investigates these enzymes in pathways germane to cancer and neurodegeneration. Contributions span foundational biology to development and characterisation of tool compound inhibitors. Work on USP30 has helped establish it as an actionable target for Parkinson’s Disease and led to a broader interest in mitophagy and pexophagy pathways.
All welcome.